Implementation of a protocol optimised for managing exclusive enteral nutrition therapy in adults with Crohn’s Disease: A pilot effectiveness-implementation study

Central Adelaide Local Health Network (CALHN)0 个研究点目标入组 50 人开始时间: 2022年3月22日最近更新: 2023年3月13日

适应症

试验速览

暂无简介。

•1. Individuals with a formal diagnosis of Crohn’s Disease which may include histology consistent with CD, clinical diagnosis of active CD or disease visible by endoscopy or radiology or an elevated FC.
•2. Active Crohn’s Disease as assessed by the treating clinician as demonstrated by:
•A. Clinical evidence with CDAI score > 150 AND/OR
•B. Radiological evidence with GIUS or magnetic resonance enterography (MRE) demonstrating active disease AND/OR
•C. Biochemical evidence with FCP > 100 microg/g
•3. Individuals under the care of an IBD Service and Gastroenterologist across the Central Adelaide Local Health Network (CALHN)
•4. Provide informed consent to participate in the study

•1.Individuals with significant medical or cognitive/psychiatric comorbidities that would impair ability to provide consent, consistently adhere to treatment or complete questionnaires required for study outcome measures
•2.Individuals where EEN was prescribed for indications of pre-surgical optimisation or downgrading of disease prior; management of abdominal abscess
•3.Individuals whose cause of symptoms is deemed to be infectious, iatrogenic or unrelated to underlying pathology of Crohn’s disease
•4.Individuals with severe co-morbidities as judged by the treating clinician

发起方

Central Adelaide Local Health Network (CALHN)